Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arand

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Cancer Research|July 9, 1999
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancerJ G Hengstler, J Lange, A Kett, et al.
International Journal of Cancer|September 30, 1999
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical eventsE Jäger, E Stockert, Z Zidianakis, et al.
DNA and Cell Biology|January 1, 1995
Gene evolution of epoxide hydrolases and recommended nomenclatureJ K Beetham, D Grant, M Arand, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 25, 1998
C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and typeB Tanner, J G Hengstler, A Luch, et al.
European Journal of Biochemistry|April 15, 1997
Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substratesF Müller, M Arand, H Frank, et al.
The Journal of Experimental Medicine|February 24, 2000
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanomaE Jäger, D Jäger, J Karbach, et al.
Archives of Orthopaedic and Trauma Surgery|January 17, 2004
Difference in metallic wear distribution released from commercially pure titanium compared with stainless steel platesG D Krischak, F Gebhard, W Mohr, et al.
Der Unfallchirurg|August 9, 2001
[Surgical treatment of injuries of the thoracolumbar transition--3: Follow-up examination. Results of a prospective multi-center study by the "Spinal" Study Group of the German Society of Trauma Surgery]C Knop, M Blauth, V Bühren, et al.
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.
Journal of Molecular Biology|October 20, 2004
Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactoseA L Rojas, R A P Nagem, K N Neustroev, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Cancer Research|July 9, 1999
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancerJ G Hengstler, J Lange, A Kett, et al.
International Journal of Cancer|September 30, 1999
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical eventsE Jäger, E Stockert, Z Zidianakis, et al.
DNA and Cell Biology|January 1, 1995
Gene evolution of epoxide hydrolases and recommended nomenclatureJ K Beetham, D Grant, M Arand, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 25, 1998
C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and typeB Tanner, J G Hengstler, A Luch, et al.
European Journal of Biochemistry|April 15, 1997
Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substratesF Müller, M Arand, H Frank, et al.
The Journal of Experimental Medicine|February 24, 2000
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanomaE Jäger, D Jäger, J Karbach, et al.
Archives of Orthopaedic and Trauma Surgery|January 17, 2004
Difference in metallic wear distribution released from commercially pure titanium compared with stainless steel platesG D Krischak, F Gebhard, W Mohr, et al.
Der Unfallchirurg|August 9, 2001
[Surgical treatment of injuries of the thoracolumbar transition--3: Follow-up examination. Results of a prospective multi-center study by the "Spinal" Study Group of the German Society of Trauma Surgery]C Knop, M Blauth, V Bühren, et al.
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.
Journal of Molecular Biology|October 20, 2004
Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactoseA L Rojas, R A P Nagem, K N Neustroev, et al.
Pageof 12